Creon® Serious Shortage Protocol Correction
Published: 13th October 2026
This Circular advises Health Boards and community pharmacy contractors that an error has been identified in the information contained within PCA(P)(2026)18, issued on 5th October 2026.
Please note that, in relation to the two UK-wide Serious Shortage Protocols (SSPs) for Creon® gastro-resistant capsules, only SSP061 (Creon® 25000) has been extended until Friday 8th January 2027. SSP060 (Creon® 10000) expired on 2nd October 2026.
The information provided on the UK-wide SSPs for Estradot® transdermal patches remains valid. These SSPs have been extended until Friday 8th January 2027. This applies to SSP079 (Estradot® 50 mcg), SSP080 (Estradot® 75 mcg), SSP081 (Estradot® 100 mcg), and SSP082 (Estradot® 25mcg).
Any amendments or extensions to existing SSPs are documented on the NHS Business Services Authority website using the following link: Serious shortage protocols (SSPs) | NHSBSA.
Enquiries
For any queries on the details of this circular, please contact the Scottish Government Pharmacy Team at PharmacyTeam@gov.scot.
